The global antibiotic market is expected to foresee significant growth over the forecast period on account of rising awareness related to their advantages in Asia Pacific. Product consumption increased by over 36% from 2000 to 2010. The companies which accounted for 76% of this increase were based in China, Brazil, India, Russia and South Africa.
Consumption of antibiotics in many countries varies significantly. By 2016 the demand for antibiotics is expected to reach over USD 44.68 billion.Two classes of antibiotic drugs including carbapenems (46%) and polymixins (13%) have shown increase in the consumption over the past few years and trend is expected to continue over the forecast period.Over the past few years numerous companies have been engaged in product manufacturing and about 79% of the global demand is covered by the antibiotics such as aminoglycoside. Moreover, there are various present in the market which contribute towards the global market for antibiotics such as tetracylines 4%, penicillin 8%, erythromycin 7%, chloramnphenicol 1% and streptomycin 1%.
Full research report on global antibiotic market analysis: http://www.grandviewresearch.com/industry-analysis/antibiotic-market
An antibiotic is a type of antimicrobial used to fight bacterial infections and slow down its growth in the body. Global antibiotic market is witnessing immense growth due to the innovation of new products and R&D investments. Antibiotic drug consumption is the leading driver of antibiotic resistance.
Antibiotic resistance and generic competition are the two foremost factors that play a significant role in the growth of industry. One of the major factors for diminishing popularity of antibacterial drugs and the reduction in its demand is antibiotic resistance. Factors such as rising demand for effective antibiotic drug and increasing prevalence of infectious diseases especially in emerging economies including Middle East, Africa, Latin America and Asia-Pacific are significant growth drivers for the product and trend is expected to continue over the forecast period.
Risinggeriatric population is one of the key drivers for the growth of the antibiotics market. The main challenge this industry is facing is emergence of drug resisting strains. As in the category of drugs, antibacterial drugs have various unique characteristics which make them little less profitable and therefore less attractive investments. Numerous antibiotic drugs are prescribed for short course of time, anywhere from 4 days to 2 weeks as compared to the medications for cholesterol and anti-hypertensive patients which lasts for several years or decades. Rise in the elderly population is also being considered as one of the major growth factors for the increasing demand for antibiotic drugs. This demand for antibiotic drugs will keep rising regardless of wide range of antibacterial drug.
Browse related reports by Grand View Research:
Innovation in technical development is the key opportunity for the market. numerous companies are continually investing to develop new products in order to increase its product line. Major attention is focusedon research and development of vital but less profitable antibacterial drug for the companies to sell at a premium price.
The demand for antibiotics is rising particularly to treat children with pneumonia and sepsis. In 2013, pneumonia was the main cause for the deaths of 935,000 deaths in children. Consumption of antibiotics worldwide grew by more than 30% from 2000 to 2010, approximately 50 billion to 70 billion standard units based on the statistics of 71 countries including the densely populated countries.
In most countries,20% products are antibiotics used by healthcare facilities and hospitals while 80% are used by the community. These are either purchased directly by consumers or prescribed by healthcare providers.
Read Our Blogs – grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more information: www.grandviewresearch.com
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:28 2nd Street, Suite 3036
City: San Francisco
Country: United States